Finance

Lists
ALC:NYSE
Alcon AG
73,60 $
-0,70%
(-0,52) 1D
16 қар., 15:36:33 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALC...
Open
74,35 $
High
74,76 $
Low
73,60 $
Mkt. cap
31,19 млрд
Avg. vol.
2,14 млн
Volume
1,27 млн
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 мың
Open
74,35 $
High
74,76 $
Low
73,60 $
Mkt. cap
31,19 млрд
Avg. vol.
2,14 млн
Volume
1,27 млн
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 мың
News stories
From web sources and news partners
Investing.com
Investing.com
·
39 минут бұрын
Why is SPDR S&P 500 ETF sliding today?
FXStreet
FXStreet
·
3 сағат бұрын
The S&P 500 will find a new leader
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 мың
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
2026 ж. 11 қар.
Fiscal period
Q3 2026
0,91 $ / 0,89 $
+2,32%beat
Revenue / Est. (USD)
2,74 млрд / 2,74 млрд
-0,16%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
2,72 млрд
2,71 млрд
2,82 млрд
2,74 млрд
Cost of goods sold
1,20 млрд
1,14 млрд
1,15 млрд
1,13 млрд
Cost of revenue
1,20 млрд
1,14 млрд
1,15 млрд
1,13 млрд
Research and development expenses
273,00 млн
245,00 млн
261,00 млн
261,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
901,00 млн
882,00 млн
964,00 млн
929,00 млн
Operating expense
1,20 млрд
1,23 млрд
1,26 млрд
1,24 млрд
Total operating expenses
2,40 млрд
2,38 млрд
2,41 млрд
2,38 млрд
Operating income
315,00 млн
330,00 млн
413,00 млн
361,00 млн
Other non operating income
-28,00 млн
-
-
1,00 млн
EBT including unusual items
264,00 млн
240,00 млн
-46,00 млн
328,00 млн
EBT excluding unusual items
268,00 млн
278,00 млн
356,00 млн
308,00 млн
Income tax expense
47,00 млн
51,00 млн
-46,00 млн
68,00 млн
Effective tax rate
17,80%
21,25%
100,00%
20,73%
Other operating expenses
29,00 млн
106,00 млн
37,00 млн
54,00 млн
Net income
217,00 млн
189,00 млн
-
260,00 млн
Net profit margin
7,98%
6,98%
-
9,50%
Earnings per share
0,78
0,85
0,84
0,91
Interest and investment income
74,00 млн
2,00 млн
-
-
Interest expense
-53,00 млн
-52,00 млн
-53,00 млн
-52,00 млн
Net interest expenses
21,00 млн
-50,00 млн
-53,00 млн
-52,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
438,00 млн
600,00 млн
676,00 млн
632,00 млн
Gain or loss from assets sale
9,00 млн
2,00 млн
2,00 млн
4,00 млн
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары